RTI Surgical Expands Facility to Advance Tissue Engineering
RTI Surgical, a prominent Contract Development and Manufacturing Organization (CDMO), is excited to announce the completion of a significant expansion to its Tutoplast® Tissue Sterilization Process facility. This $15 million investment manifests as a 5,000 square-foot clean room, aimed at enhancing the stark capabilities in producing regulated tissues for regenerative medicine.
Innovative Improvements to Meet Growing Demand
The newly expanded facility comes as a strategic answer to the increasing demand for Tutoplast® processed implants. These implants are crucial in various medical applications spanning plastic and reconstructive surgery, sports medicine, orthopedics, and neuro-spine surgeries. This advancement will also support the clinical testing of Cortiva® Allograft Dermis (ADM), a key product used in implant-based breast reconstruction, ensuring that patients receive efficient and safe medical solutions.
The Importance of the Tutoplast® Process
The Tutoplast® Tissue Sterilization Process exemplifies RTI Surgical's dedication to preserving human tissue integrity before implantation, which is essential for efficacy and safety. This advanced sterilization technique not only protects biological materials but also improves the overall manufacturing process. By incorporating the latest advancements in healthcare technology, RTI is positioned to serve its OEM customers better while adhering to rigorous quality standards in patient care.
Leadership Insights on Facility Expansion
Olivier Visa, President and Chief Executive Officer of RTI Surgical, expressed enthusiasm about the facility's expansion, stating, “This development is a testament to our commitment to innovation and excellence in regenerative medicine. It reflects our dedication to providing tailored solutions for our partners while supporting the broader healthcare community.” Such expansions not only benefit RTI's manufacturing capabilities but also foster growth within the community they serve.
RTI Surgical's Role in the Medical Landscape
RTI Surgical operates at the forefront of regenerative medicine, collaborating closely with Original Equipment Manufacturers (OEMs) to tackle clinical challenges. Through innovative technology and biological materials, the company develops customized solutions. Their focus areas include diverse segments such as cardiac health, orthopedics, and extensive soft tissue repair.
Company Structure and Operations
Headquartered in Alachua, Florida, RTI Surgical has established itself as a leader with operations spanning the United States and Europe. The company's commitment to quality ensures that both patients and healthcare practitioners can trust their products' effectiveness.
Future Directions and Community Impact
With this latest expansion, RTI Surgical is poised to make significant contributions to the field of regenerative medicine. As they ramp up production capabilities, the investment is expected to create further opportunities, not only within the company but also in strengthening ties to the community. Their commitment to advancing patient care through innovative solutions remains unwavering.
Frequently Asked Questions
What is the purpose of RTI Surgical's facility expansion?
The expansion aims to enhance the manufacturing capabilities of the Tutoplast® Tissue Sterilization Process, addressing the growing demand for advanced medical implants.
How does the Tutoplast® process benefit patients?
This process preserves human tissue, ensuring safety and efficacy in implants used across a variety of medical applications, leading to better patient outcomes.
What products does RTI Surgical specialize in?
RTI Surgical specializes in regenerative medicine products, particularly focusing on soft tissue repairs, orthopedic solutions, and implants for reconstructive surgeries.
Who is leading the facility expansion at RTI Surgical?
Olivier Visa serves as the President and Chief Executive Officer, guiding RTI Surgical's strategic investments in innovations and advancements in tissue engineering.
Where is RTI Surgical headquartered?
RTI Surgical is headquartered in Alachua, Florida, with additional manufacturing operations throughout the United States and Europe.
